Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Gains from Sales and Divestitures (2016)

Historic Gains from Sales and Divestitures for Microbot Medical (MBOT) over the last 4 years, with Q3 2016 value amounting to $194620.0.

  • Microbot Medical's Gains from Sales and Divestitures rose 12242.29% to $194620.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $194620.0, marking a year-over-year increase of 12242.29%. This contributed to the annual value of $1.5 million for FY2015, which is N/A changed from last year.
  • Microbot Medical's Gains from Sales and Divestitures amounted to $194620.0 in Q3 2016, which was up 12242.29% from $32078.0 recorded in Q2 2016.
  • In the past 5 years, Microbot Medical's Gains from Sales and Divestitures registered a high of $1.5 million during Q4 2015, and its lowest value of $22500.0 during Q3 2014.
  • In the last 4 years, Microbot Medical's Gains from Sales and Divestitures had a median value of $297067.5 in 2014 and averaged $408267.4.
  • Per our database at Business Quant, Microbot Medical's Gains from Sales and Divestitures skyrocketed by 28888.89% in 2015 and then plummeted by 9463.13% in 2016.
  • Quarter analysis of 4 years shows Microbot Medical's Gains from Sales and Divestitures stood at $565883.0 in 2013, then soared by 50.42% to $851216.0 in 2014, then skyrocketed by 77.42% to $1.5 million in 2015, then tumbled by 87.11% to $194620.0 in 2016.
  • Its Gains from Sales and Divestitures stands at $194620.0 for Q3 2016, versus $32078.0 for Q2 2016 and $217919.0 for Q1 2016.